Live Earnings Conference Call: Viking Therapeutics will host a live Q3 2025 earnings call on October 22, 2025 at 4:30PM ET. Follow this link to get details and listen to Viking Therapeutics' Q3 2025 earnings call when it goes live. Get details. Viking Therapeutics (VKTX) News Today $31.29 -1.69 (-5.13%) As of 03:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VKTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Earnings Preview For Viking TherapeuticsOctober 21 at 7:38 PM | benzinga.comViking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with ObesityOctober 21 at 7:05 AM | prnewswire.comViking Therapeutics (VKTX): Exploring Valuation as Investor Optimism Grows for Obesity Drug Pipeline and Earnings ReleaseOctober 19 at 7:09 PM | uk.finance.yahoo.comViking Therapeutics (VKTX) Receives a Buy from OppenheimerOctober 17, 2025 | finance.yahoo.comViking Therapeutics (NASDAQ:VKTX) Trading Down 3.4% - Time to Sell?October 17, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Gap Down - Here's What HappenedOctober 17, 2025 | marketbeat.comEli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?October 17, 2025 | fool.comRFG Advisory LLC Acquires 25,387 Shares of Viking Therapeutics, Inc. $VKTXOctober 16, 2025 | marketbeat.comViking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025October 15, 2025 | prnewswire.comViking Therapeutics (VKTX) Projected to Post Earnings on WednesdayOctober 15, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 2.5% - Should You Sell?October 14, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 1% - What's Next?October 13, 2025 | marketbeat.comIFP Advisors Inc Acquires 10,048 Shares of Viking Therapeutics, Inc. $VKTXOctober 13, 2025 | marketbeat.comViking Therapeutics, Inc. $VKTX Shares Acquired by Blair William & Co. ILOctober 12, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 4.1% - What's Next?October 10, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Purchases New Stake in Viking Therapeutics, Inc. $VKTXOctober 10, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 8.1% - Should You Buy?October 10, 2025 | marketbeat.comViking Therapeutics, Inc. (NASDAQ:VKTX) Given Average Rating of "Moderate Buy" by BrokeragesOctober 9, 2025 | marketbeat.comViking Therapeutics' (VKTX) Sell (D-) Rating Reaffirmed at Weiss RatingsOctober 8, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 2.6% - Here's WhyOctober 8, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Down 2.3% - Here's WhyOctober 7, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 8.6% - Here's What HappenedOctober 6, 2025 | marketbeat.comWhy Viking Therapeutics (VKTX) Is Up 15.1% After Acquisition Buzz and Analyst Focus on Its PipelineOctober 6, 2025 | finance.yahoo.comViking Therapeutics:Â A Speculative BuyOctober 4, 2025 | seekingalpha.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 6.6% - What's Next?October 3, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Up 1.9% - Should You Buy?October 2, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Stock Price Up 4.1% - Should You Buy?October 1, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Shares Up 1.8% - Here's WhySeptember 30, 2025 | marketbeat.comBTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX) With a $125 PTSeptember 30, 2025 | insidermonkey.comBTIG Reiterates a Buy Rating on Viking Therapeutics (VKTX)September 30, 2025 | msn.comViking Therapeutics' (VKTX) "Buy" Rating Reaffirmed at HC WainwrightSeptember 29, 2025 | marketbeat.comViking Therapeutics: Overdue For GainsSeptember 28, 2025 | seekingalpha.comViking Therapeutics (NASDAQ:VKTX) Shares Down 5.8% - Here's WhySeptember 25, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading 6.6% Higher - Time to Buy?September 24, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading 7.4% Higher - What's Next?September 24, 2025 | marketbeat.comU.S. Capital Wealth Advisors LLC Purchases 27,795 Shares of Viking Therapeutics, Inc. $VKTXSeptember 24, 2025 | marketbeat.comPfizer’s $5B Bet on Metsera ($MTSR) vs Viking Therapeutics ($VKTX)September 23, 2025 | msn.comViking Therapeutics, Inc. (VKTX) Presents at Bernstein 2nd Annual Global Healthcare Conference TranscriptSeptember 23, 2025 | seekingalpha.comExchange Traded Concepts LLC Buys 20,296 Shares of Viking Therapeutics, Inc. $VKTXSeptember 23, 2025 | marketbeat.comViking Therapeutics: Oral Study Disappoints, Competitor Gets Bought Out (Rating Downgrade)September 23, 2025 | seekingalpha.comViking Therapeutics, Inc. (VKTX) Q4 2023 Earnings Call TranscriptSeptember 22, 2025 | seekingalpha.comViking Therapeutics (NASDAQ:VKTX) Earns Buy Rating from BTIG ResearchSeptember 22, 2025 | marketbeat.comKingstone Capital Partners Texas LLC Makes New $1.37 Million Investment in Viking Therapeutics, Inc. $VKTXSeptember 22, 2025 | marketbeat.comStrs Ohio Takes Position in Viking Therapeutics, Inc. $VKTXSeptember 21, 2025 | marketbeat.comViking Therapeutics (NASDAQ:VKTX) Trading Up 10.6% - Should You Buy?September 19, 2025 | marketbeat.comPrediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 MonthsSeptember 19, 2025 | fool.comViking Therapeutics, Inc. $VKTX Shares Sold by Harbor Capital Advisors Inc.September 18, 2025 | marketbeat.comViking Therapeutics, Inc. (VKTX): A Bull Case TheorySeptember 18, 2025 | finance.yahoo.comBiotech Breakouts: 3 Stocks With Massive Upside Potential (VKTX)Biotech stocks are highly volatile; however, these biotech stocks have key trial results this fall that could spark sharp moves and long-term growth potential...September 17, 2025 | marketbeat.comWesbanco Bank Inc. Has $1.38 Million Holdings in Viking Therapeutics, Inc. $VKTXSeptember 17, 2025 | marketbeat.com Get Viking Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VKTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VKTX Media Mentions By Week VKTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VKTX News Sentiment▼0.280.50▲Average Medical News Sentiment VKTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VKTX Articles This Week▼914▲VKTX Articles Average Week Get the Latest News and Ratings for VKTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Viking Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Madrigal Pharmaceuticals News Today Eli Lilly and Company News Today Summit Therapeutics News Today Ascendis Pharma A/S News Today Dr. Reddy's Laboratories News Today Roivant Sciences News Today Viatris News Today Qiagen News Today Elanco Animal Health News Today BridgeBio Pharma News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VKTX) was last updated on 10/22/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredTrump cannot stop this trainThe Nobel Committee just confirmed what free-market thinkers have long argued — that true wealth isn’t built t...Porter & Company | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viking Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viking Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VKTX Stock Alerts